Pharmacy

Your Article Summary

See Latest Articles

Warnings beefed up on OTC analgesics, antipyretics
American Pharmacists Association, 04/30/09

FDA announced the final ruling on new, more stringent packaging and warning label requirements for OTC pain relievers and fever reducers containing acetaminophen and NSAIDs at a briefing. Internal analgesics, antipyretics and antirheumatic drug products are all affected by this ruling. Matthew Holman, PhD, Deputy Director, Division of Nonprescription Regulation Development, Office of Nonprescription Products, Office of New Drugs, Center for Drug Evaluation and Research, FDA; and Charles Ganley, MD, Director, Office of Nonprescription Products, Office of New Drugs, CDER, FDA, addressed press questions and spelled out the requirements, which were originally stated in December 2006.

Today in Other Drugs...keeping you current

Receive free subspecialty "5-minute updates" via email

Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability
Journal of Pharmacy and Pharmacology, 12/15/09

Novel TNF antagonists for the treatment of rheumatoid arthritis
Expert Opinion on Investigational Drugs, 12/15/09

Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
Genentech, 12/15/09

 See all of Other Drugs

Today in Over The Counter (OTC)...keeping you current

Receive free subspecialty "5-minute updates" via email

Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin
Preventive Cardiology, 12/15/09

Medication Usage and the Risk of Neoplasia in Patients With Barretts Esophagus
Clinical Gastroenterology and Hepatology , 12/15/09

Supply of over-the-counter weight-loss products from community pharmacies
International Journal of Pharmacy Practice, 12/08/09

 See all of Over The Counter (OTC)